Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells

镰状细胞病诱导造血干细胞循环的机制和后果

基本信息

项目摘要

Project Summary Sickle cell disease (SCD) is a painful debilitating life-long condition resulting from mutations in the gene encoding hemoglobin β subunit, causing abnormal hemoglobin polymerization leading to hemolysis, repeated vasooclusion, and chronic systemic inflammation resulting in substantial global morbidity and early mortality. Curative therapy for SCD relies on hematopoietic stem cell (HSC) transplantation, however the damaging effects of SCD pathophysiology on HSCs remain uncharacterized and we seek to fill this gap in current knowledge. Our preliminary studies show that HSCs display increased cycling in a transgenic SCD mouse model upon aging, and myeloid lineage biased in vitro differentiation of SCD patient derived HSCs. As a postdoctoral fellow in the McKinney-Freeman laboratory, I will investigate the functional consequences and molecular mechanisms underlying SCD mediated HSC cycling in a murine model and translate these findings to human HSC during SCD. In Aim 1, I will use colony formation assays, limiting dilution primary and secondary HSC transplantation, and serial exposure to chemotherapy to assess the detrimental impact of SCD-induced cycling on HSC frequency and function. In Aim 2, I will probe the molecular and epigenetic dysregulation underlying increased HSC cycling during SCD. HSCs isolated from SCD and control mice will be subjected to bulk RNA-seq and ATAC-seq to define transcriptional dysregulation correlated with changes in gene promoter accessibility meditating increased cycling. Finally, I will translate our findings to humans by interrogating cell cycle dysregulation in HSCs isolated from SCD patients (Aim 3). SCD patient-derived bone marrow aspirates will be profiled for frequency of phenotypic HSCs and alterations in cell cycle status by flow cytometry and ex vivo EdU incorporation. Lineage potential and hematopoietic output of SCD HSCs will be analyzed by colony formation and in vitro single HSC differentiation assays. Lastly, SCD HSC repopulating potential and self-renewal will be examined by limiting dilution primary and secondary transplantation into human cytokine expressing immune deficient mice. Together the proposed studies serve to deepen our understanding of a previously unexplored aspect of HSC biology by examining the impact of SCD. Greater understanding of SCD mediated mechanisms of HSC impairment become exceptionally important as autologous HSC transplantation following gene editing or gene therapy for SCD improve and increase in frequency. These aims draw on my prior training in cancer biology of hematologic malignancies but also provide abundant novel training opportunities in the field of HSC biology and for professional career development. The McKinney-Freeman lab and St. Jude Children’s Research Hospital are ideal environments in which to receive training in the study HSC biology, combining state-of-the-art institutional resources, career development resources, and excellent mentorship with the singular goal of advancing to an independent academic primary investigator position.
项目摘要 镰状细胞疾病(SCD)是由于编码基因突变而导致的痛苦的衰弱终身状况 血红蛋白β亚基,导致异常血红蛋白聚合导致溶血,重复 血管肿块和慢性全身性炎症导致了大量的全球发病率和早期死亡率。 SCD治疗疗法依赖于造血干细胞(HSC)移植,但是有害影响 HSC上的SCD病理生理学仍然没有表征,我们试图在当前知识中填补这一空白。我们的 初步研究表明,HSC在衰老后的转基因SCD小鼠模型中显示出增加的循环。 SCD患者衍生的HSC的体外分化偏差。作为博士后家伙 麦金尼 - 弗里曼实验室,我将研究功能后果和分子机制 鼠模型中的基础SCD介导的HSC循环,并将这些发现转化为人类HSC scd。在AIM 1中,我将使用菌落形成测定法,限制稀释初级和次级HSC移植, 以及连续暴露于化学疗法,以评估SCD诱导的循环对HSC的有害影响 频率和功能。在AIM 2中,我将探测增加的分子和表观遗传失调的增加 SCD期间的HSC骑自行车。从SCD和对照小鼠中分离出的HSC将受到散装RNA-seq和 ATAC-SEQ定义转录失调与基因启动子可及性的变化相关 冥想增加的循环。最后,我将通过询问细胞周期将我们的发现转化为人类 从SCD患者分离出的HSC的失调(AIM 3)。 SCD患者衍生的骨髓抽吸将是 介绍了表型HSC的频率以及通过流式细胞仪和EX VIVO EDU改变细胞周期状态的频率 并入。 SCD HSC的谱系潜力和造血输出将通过菌落形成分析 和体外单HSC分化测定法。最后,SCD HSC重新流动潜力和自我更新将是 通过将稀释原发性和继发移植限制为表达免疫的人类细胞因子进行检查 不足的小鼠。拟议的研究共同加深了我们对以前出乎意料的理解 HSC生物学的方面通过检查SCD的影响。对SCD介导的机制的更多了解 由于基因编辑后自体HSC移植,HSC损伤变得异常重要 或用于SCD的基因疗法改善和增加频率。这些目标借鉴了我先前在癌症方面的培训 血液学恶性肿瘤的生物学,但在HSC领域也提供了丰富的新型培训机会 生物学和职业发展。麦金尼 - 弗里曼实验室和圣裘德儿童研究 医院是接受研究HSC生物学培训的理想环境,结合了最先进的环境 机构资源,职业发展资源和出色的心态,其目标是 晋升为独立的学术主要研究者职位。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aditya Shirish Barve其他文献

Aditya Shirish Barve的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aditya Shirish Barve', 18)}}的其他基金

Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells
镰状细胞病诱导造血干细胞循环的机制和后果
  • 批准号:
    10464657
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:

相似国自然基金

阵发性睡眠性血红蛋白尿症异常克隆扩增的分子机制及干预研究
  • 批准号:
    82370121
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
针挑督脉改善血红蛋白alpha、beta亚基异常分子结构及红细胞携氧-释氧热力学、动力学治疗肿瘤相关性疲劳的机制研究
  • 批准号:
    82205310
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
MIB2泛素化降解SUZ12参与调控阵发性睡眠性血红蛋白尿症异常克隆增殖的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
MIB2泛素化降解SUZ12参与调控阵发性睡眠性血红蛋白尿症异常克隆增殖的分子机制研究
  • 批准号:
    82270142
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目

相似海外基金

A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 7.18万
  • 项目类别:
Protein arginine methyltransferase-mediated vascular dementia in sickle cell disease
镰状细胞病中蛋白质精氨酸甲基转移酶介导的血管性痴呆
  • 批准号:
    10662136
  • 财政年份:
    2023
  • 资助金额:
    $ 7.18万
  • 项目类别:
Mechanisms and consequences of sickle cell disease-induced cycling in hematopoietic stem cells
镰状细胞病诱导造血干细胞循环的机制和后果
  • 批准号:
    10464657
  • 财政年份:
    2022
  • 资助金额:
    $ 7.18万
  • 项目类别:
Bone Marrow Niche dysfunction in sickle cell disease
镰状细胞病的骨髓生态位功能障碍
  • 批准号:
    10250697
  • 财政年份:
    2021
  • 资助金额:
    $ 7.18万
  • 项目类别:
Bone Marrow Niche dysfunction in sickle cell disease
镰状细胞病的骨髓生态位功能障碍
  • 批准号:
    9927706
  • 财政年份:
    2019
  • 资助金额:
    $ 7.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了